Clinical trial · Interventional
Pegfilgrastim PBPC Mobilization Study
Randomized, Double-Blind Study of Peripheral Blood Progenitor Cell (PBPC) Mobilization by Pegfilgrastim or Filgrastim for Autologous Transplantation in Subjects With Hodgkin's or Non-Hodgkin's Lymphoma.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a randomized, double-blind, multi-center study to assess the safety and effectiveness of using a single subcutaneous (under the skin) injection of pegfilgrastim or daily subcutaneous injections of Filgrastim to mobilize stem cells for autologous transplantation in patients with Hodgkin's or non-Hodgkin's lymphoma.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hematology | — | UNRESOLVED | — |
| Hodgkin's Lymphoma | Hodgkin Lymphoma | ALIAS | 0.90 |
| Lymphoma | Lymphoma | ONTOLOGY_EXACT | 0.90 |
| Non-Hodgkin's Lymphoma | Non-Hodgkin Lymphoma | ALIAS | 0.90 |
| Oncology | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| filgrastim | Drug | Filgrastim | ALIAS |
| pegfilgrastim 12 mg | Drug | Pegfilgrastim | ALIAS |
| pegfilgrastim 6 mg | Drug | Pegfilgrastim | ALIAS |
Design
Arms and outcomes
Arms (3)
- type
- EXPERIMENTAL
- label
- Pegfilgrastim 6 mg
- description
- Pegfilgrastim 6 mg given once for PBPC mobilization
- interventionNames
- Drug: pegfilgrastim 6 mg
- type
- EXPERIMENTAL
- label
- Pegfilgrastim 12 mg
- description
- Pegfilgrastim 12 mg given once for PBPC mobilization
- interventionNames
- Drug: pegfilgrastim 12 mg
- type
- ACTIVE_COMPARATOR
- label
- filgrastim
- description
- Filgrastim given daily for PBPC mobilization
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
* Hodgkin's or non-Hodgkin's lymphoma patients suitable for an autologous PBPC transplant - No previous bone marrow or PBPC transplant
References
Publications (0)
Data not yet available